SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 41 filers reported holding SAB BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $69,720 | +88.6% | 84,000 | 0.0% | 0.00% | +100.0% |
Q1 2023 | $36,960 | -25.4% | 84,000 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $49,552 | -16.0% | 84,000 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $59,000 | -51.6% | 84,000 | 0.0% | 0.00% | -33.3% |
Q2 2022 | $122,000 | – | 84,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First PREMIER Bank | 652,440 | $946,000 | 0.28% |
METEORA CAPITAL, LLC | 292,538 | $424,000 | 0.08% |
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 78,115 | $113,000 | 0.02% |
SILVER OAK SECURITIES, Inc | 51,941 | $64,000 | 0.01% |
Shaolin Capital Management LLC | 275,000 | $399,000 | 0.01% |
Elgethun Capital Management | 13,296 | $18,000 | 0.01% |
LGL PARTNERS, LLC | 23,000 | $33,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,000 | $122,000 | 0.00% |
Spectrum Management Group, LLC | 5,030 | $7,000 | 0.00% |
Veritable, L.P. | 43,551 | $63,000 | 0.00% |